NCT01333436View on ClinicalTrials.gov

A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)

NACompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

July 20, 2011

Primary Completion Date

May 12, 2012

Study Completion Date

May 12, 2012

Conditions
DyslipidemiaHypercholesterolemia
Interventions
OTHER

Test Meal

During Visit 2, a test meal will be supplied by the Sponsor of approximately 944 kcal (57% fat, 31% carbohydrate, and 12% protein), and postprandial blood draws will be done at 1, 2, 3, 4, and 6 hours after the meal.

Trial Locations (1)

121-705

MSD Korea Ltd., Seoul

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01333436 - A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1) | Biotech Hunter | Biotech Hunter